Literature DB >> 30595042

Seizure in Alzheimer's Disease: An Underestimated Phenomenon.

Marjan Asadollahi1, Musa Atazadeh2, Maryam Noroozian3.   

Abstract

Alzheimer's disease (AD) is considered as a potential risk factor for the development of seizure due to neurodegeneration and imbalance between stimulatory and inhibitory circuits in the brain. Seizure could occur in any point during the course of AD, and its presentation varies from fluctuation in cognitive domains to more typical seizures. The clinical diagnosis of seizure in patients with dementia may be challenging due to difficulty in history taking and clinical assessment. No paraclinic methods other than electroencephalogram (EEG) could provide arguments for the diagnosis of AD-related seizures (neither imaging modalities nor cerebrospinal fluid biomarkers). Standard 30-minute EEG may not be sufficiently sensitive to detect epileptiform discharges. In the present study, we aim to review different aspects of seizure in AD, including seizure prevalence, risk factors, underlying mechanisms, electroencephalographic findings, clinical presentations, impact of seizures on AD, and treatment options.

Entities:  

Keywords:  Alzheimer’s disease; cognitive impairment; dementia; seizure

Year:  2018        PMID: 30595042     DOI: 10.1177/1533317518813551

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  6 in total

1.  Elevated TNF-α Leads to Neural Circuit Instability in the Absence of Interferon Regulatory Factor 8.

Authors:  Philip A Feinberg; Shannon C Becker; Leeyup Chung; Loris Ferrari; David Stellwagen; Christelle Anaclet; Violeta Durán-Laforet; Travis E Faust; Rachita K Sumbria; Dorothy P Schafer
Journal:  J Neurosci       Date:  2022-07-05       Impact factor: 6.709

Review 2.  Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress.

Authors:  Nicole G Rummel; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2021-12-21       Impact factor: 7.468

Review 3.  Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.

Authors:  Miren Altuna; Gonzalo Olmedo-Saura; María Carmona-Iragui; Juan Fortea
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

4.  Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases.

Authors:  Simote T Foliaki; Benjamin Schwarz; Bradley R Groveman; Ryan O Walters; Natalia C Ferreira; Christina D Orrù; Anna Smith; Aleksandar Wood; Olivia M Schmit; Phoebe Freitag; Jue Yuan; Wenquan Zou; Catharine M Bosio; James A Carroll; Cathryn L Haigh
Journal:  Mol Brain       Date:  2021-10-11       Impact factor: 4.041

5.  A peptide blocking the ADORA1-neurabin interaction is anticonvulsant and inhibits epilepsy in an Alzheimer's model.

Authors:  Shalini Saggu; Yunjia Chen; Liping Chen; Diana Pizarro; Sandipan Pati; Wen Jing Law; Lori McMahon; Kai Jiao; Qin Wang
Journal:  JCI Insight       Date:  2022-06-08

6.  Precuneus-Dominant Degeneration of Parietal Lobe Is at Risk of Epilepsy in Mild Alzheimer's Disease.

Authors:  Andras Horvath; Mate Kiss; Anna Szucs; Anita Kamondi
Journal:  Front Neurol       Date:  2019-08-22       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.